荃信生物-B11月20日斥资99.78万港元回购4.68万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) Zhi Tong Cai Jing·2025-11-20 11:42

Core Viewpoint - The company announced a share buyback program, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company repurchased 46,800 shares at a total cost of HKD 997,800 [1] - The buyback price per share ranged from HKD 21 to HKD 21.5 [1]